Welcome to our dedicated page for ZIMVIE news (Ticker: ZIMV), a resource for investors and traders seeking the latest updates and insights on ZIMVIE stock.
ZimVie Inc. reports developments in its dental implant and digital dentistry business, including product launches, distribution arrangements, operating results, and corporate governance matters. The company develops, manufactures, and delivers products and solutions for dental tooth replacement and restoration, including dental implants, biomaterials, and digital workflow tools.
Recurring updates include commercial expansion in international dental markets, launches of the RealGUIDE Software Suite and Implant Concierge service, and commercial arrangements that extend access to ZimVie implant systems. Company news also includes capital-structure disclosures, stockholder voting matters, material agreements, and clinical or regulatory disclosures tied to its dental products and technology portfolio.
ZimVie Inc. began trading on the Nasdaq under the symbol ZIMV on March 1, 2022, marking its debut as an independent company following its separation from Zimmer Biomet. This strategic move aims to enhance the company's focus on its Dental and Spine product platforms, which together represent a $20 billion addressable market. ZimVie appointed a new Board of Directors with diverse healthcare experience to guide its growth and shareholder value.